PARP inhibitors were all but written off a few years ago, but now are back with a focus on BRCA1 and BRCA2 mutation-related cancers, the Wall Street Journal reports.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.
Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.
Broken links are found throughout academic publications, and some services are trying to combat such link decay.
Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.